Mithra Group, founded in 2004, has a main department in Boston and primarily invests in pharmaceutical and healthcare startups that are 4-5 years old. Their portfolio includes Momenta Pharmaceuticals and MacroGenics, and they typically invest $50-100 million per startup. Mithra Ventures has a higher average lead investment amount compared to other organizations and has a higher rate of exits. They are active in less than 2 investment rounds annually and typically invest in rounds with 7-8 participants. They often co-invest with TPG, Red Abbey Venture Partners, and Polaris Partners.